TY - JOUR
T1 - Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
AU - Dillner, Lena
AU - Pagliusi, Sonia
AU - Bray, Freddie
AU - Lorincz, Attila
AU - Kjaer, Susanne K
AU - Anttila, Ahti
AU - Iversen, Ole Eric
AU - Dillner, Joakim
AU - Lehtinen, Matti
AU - Paavonen, Jorma
PY - 2008
Y1 - 2008
N2 - Disease trend studies based on birth cohort analysis and serological studies indicate that recent generations have a higher prevalence of oncogenic Human Papilloma Virus (HPV) types, and are likely to be at higher risk of cancer than previous generations. This implies that prevention strategies to protect young populations from HPV-associated cancers need to be strengthened, and hence organized implementation of vaccination and better screening programs are being considered. In this context, randomized large-scale policy evaluations will be instrumental in accelerating disease control and improve effective prevention programs. This report shares experiences from Nordic countries with examples of prevention strategies through vaccination and cervical screening. The same principles as set up for organized programs and new HPV technologies may apply for screening and vaccination as key tools to eliminate cervical cancer in the Nordic countries and globally.
AB - Disease trend studies based on birth cohort analysis and serological studies indicate that recent generations have a higher prevalence of oncogenic Human Papilloma Virus (HPV) types, and are likely to be at higher risk of cancer than previous generations. This implies that prevention strategies to protect young populations from HPV-associated cancers need to be strengthened, and hence organized implementation of vaccination and better screening programs are being considered. In this context, randomized large-scale policy evaluations will be instrumental in accelerating disease control and improve effective prevention programs. This report shares experiences from Nordic countries with examples of prevention strategies through vaccination and cervical screening. The same principles as set up for organized programs and new HPV technologies may apply for screening and vaccination as key tools to eliminate cervical cancer in the Nordic countries and globally.
KW - Uterine Cervical Neoplasms: virology
KW - Uterine Cervical Neoplasms: prevention & control
KW - Uterine Cervical Neoplasms: immunology
KW - Papillomavirus Vaccines: therapeutic use
KW - Papillomavirus Vaccines: immunology
KW - Papillomavirus Infections: virology
KW - Papillomavirus Infections: prevention & control
KW - Papillomaviridae: immunology
KW - Papillomavirus Infections: immunology
U2 - 10.1080/00016340801986771
DO - 10.1080/00016340801986771
M3 - Review article
SN - 1600-0412
VL - 87
SP - 489
EP - 498
JO - Acta Obstetricia et Gynecologica Scandinavica
JF - Acta Obstetricia et Gynecologica Scandinavica
IS - 5
ER -